Dianthus Therapeutics, Inc.
DNTH- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001690585
In the last 90 days, Dianthus Therapeutics, Inc. insiders filed 0 open-market purchases and 8 sales; 269 institutions reported holding it in 13F filings for Q2 2026, worth $6.43B in total; no superinvestor holds it.
13F holders, Q4 2023
Institutional positions in Dianthus Therapeutics, Inc. as of Dec 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 39
- +9 vs. Q3 2023
- Shares held
- 10.3M
- +218.5K (+2.2%) vs. Q3 2023
- Total value
- $106.5M
- −$29.8M (−21.9%) vs. Q3 2023
- New holders
- 10
- 10 more added
- Sold out
- 1
- 7 more reduced
Compare with Q3 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting DNTH on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 269 | $6.43B |
| Q1 2026 | 241 | $5.37B |
| Q4 2025 | 166 | $2.02B |
| Q3 2025 | 140 | $1.85B |
| Q2 2025 | 103 | $728.6M |
| Q1 2025 | 99 | $685.5M |
| Q4 2024 | 96 | $765.7M |
| Q3 2024 | 91 | $859.0M |
| Q2 2024 | 74 | $769.0M |
| Q1 2024 | 76 | $784.0M |
| Q4 2023 | 39 | $109.9M |
| Q3 2023 | 30 | $136.3M |
| Q2 2023 | 46 | $22.0M |
| Q1 2023 | 52 | $23.6M |
| Q4 2022 | 54 | $11.1M |
| Q3 2022 | 72 | $70.5M |
| Q2 2022 | 75 | $54.6M |
| Q1 2022 | 93 | $138.9M |
| Q4 2021 | 94 | $211.6M |
| Q3 2021 | 93 | $276.0M |
| Q2 2021 | 97 | $366.3M |
| Q1 2021 | 90 | $423.5M |
Institutions, Q4 2023
Shares, value and share of portfolio for each institution holding Dianthus Therapeutics, Inc.; share changes are against Q3 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| FMR LLC | 2,218,212 | $22.6M | 0.00% | 00.0% | Unchanged |
| Fairmount Funds Management LLC | 1,928,503 | $20.1M | 2.12% | 00.0% | Unchanged |
| 5AM Venture Management, LLC | 1,472,264 | $15.3M | 4.06% | 00.0% | Unchanged |
| Avidity Partners Management LP | 1,217,554 | $12.7M | 0.48% | 00.0% | Unchanged |
| VR Adviser, LLC | 927,706 | $9.65M | 0.66% | 00.0% | Unchanged |
| Octagon Capital Advisors LP | 554,000 | $5.76M | 0.92% | +74,000+15.4% | Added |
| Tang Capital Management LLC | 504,242 | $5.24M | 0.48% | −87,394−14.8% | Reduced |
| Nantahala Capital Management, LLC | 328,433 | $3.42M | 0.34% | −8,429−2.5% | Reduced |
| Atlas Venture Life Science Advisors, LLC | 236,979 | $2.46M | 0.29% | 00.0% | Unchanged |
| Alphabet Inc. | 208,697 | $2.17M | 0.10% | 00.0% | Unchanged |
| Vanguard Group Inc | 153,646 | $1.60M | 0.00% | +26,769+21.1% | Added |
| Vestal Point Capital, LP | 135,000 | $1.40M | 0.15% | +135,000 | New |
| Renaissance Technologies LLC | 49,306 | $513.0K | 0.00% | +14,090+40.0% | Added |
| Geode Capital Management, LLC | 45,179 | $469.9K | 0.00% | +18,838+71.5% | Added |
| Fred Alger Management, LLC | 40,841 | $424.7K | 0.00% | +40,841 | New |
| Millennium Management LLC | 33,964 | $353.2K | 0.00% | +33,964 | New |
| BlackRock Inc. | 32,306 | $336.0K | 0.00% | +155+0.5% | Added |
| Susquehanna International Group, LLP | 28,679 | $298.3K | 0.00% | +28,679 | New |
| Laurion Capital Management LP | 26,267 | $273.2K | 0.01% | −10,126−27.8% | Reduced |
| ArrowMark Colorado Holdings LLC | 20,788 | $216.2K | 0.00% | 00.0% | Unchanged |
| Acadian Asset Management LLC | 17,888 | $184.0K | 0.00% | −4,411−19.8% | Reduced |
| Citigroup Inc | 17,407 | $181.0K | 0.00% | +13,539+350.0% | Added |
| Jane Street Group, LLC | 15,678 | $163.1K | 0.00% | +15,678 | New |
| Northern Trust Corp | 15,301 | $159.1K | 0.00% | +15,301 | New |
| Bessemer Group Inc | 14,829 | $154.0K | 0.00% | 00.0% | Unchanged |
| Dimensional Fund Advisors LP | 14,736 | $153.3K | 0.00% | +14,736 | New |
| Jefferies Financial Group Inc. | 13,200 | $137.3K | 0.00% | 00.0% | Unchanged |
| RBF Capital, LLC | 10,784 | $112.2K | 0.01% | −4,892−31.2% | Reduced |
| Bank of America Corp | 4,129 | $42.9K | 0.00% | +4,007+3,284.4% | Added |
| Tower Research Capital LLC (TRC) | 2,430 | $25.3K | 0.00% | +2,430 | New |
| Qube Research & Technologies Ltd | 802 | $8.34K | 0.00% | +799+26,633.3% | Added |
| ADAR1 Capital Management, LLC | 481 | $5.00K | 0.00% | +481 | New |
| Royal Bank of Canada | 335 | $4.00K | 0.00% | −4−1.2% | Reduced |
| UBS Group AG | 380 | $3.95K | 0.00% | +61+19.1% | Added |
| Wells Fargo & Company | 74 | $769 | 0.00% | +24+48.0% | Added |
| Morgan Stanley | 55 | $572 | 0.00% | −100−64.5% | Reduced |
| JPMorgan Chase & Co | 41 | $426 | 0.00% | 00.0% | Unchanged |
| Institutional & Family Asset Management, LLC | 3 | $31 | 0.00% | 00.0% | Unchanged |
| Barclays PLC | 3 | $31 | 0.00% | +3 | New |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −105,561−100.0% | Sold out |